Status:
COMPLETED
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco-Related Carcinoma
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytob...
Detailed Description
PRIMARY OBJECTIVES: I. Identify absolute and relative risk anti-tobacco messages that effectively communicate polytobacco risks to lesbian, gay, bisexual, transgender (LGBT) young adults. Participan...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Young adults (age 18-35 years)
- Live in the United States
- At least 50% of the sample also:
- Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)
Exclusion
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2022
Estimated Enrollment :
2849 Patients enrolled
Trial Details
Trial ID
NCT05393869
Start Date
April 14 2021
End Date
November 14 2022
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210